New method may provide more effective treatments of many lung diseases
Researchers from Columbia Engineering and Columbia University Medical Center (CUMC) have developed a new method that can target delivery of very small volumes of drugs into the lung.
Their approach, in which micro-liters of liquid containing a drug are instilled into the lung, distributed as a thin film in the predetermined region of the lung airway, and absorbed locally, may provide much more effective treatment of lung disease. The work was published in the August 31 online Early Edition of Proceedings of the National Academy of Sciences (PNAS).
Lungs are susceptible to many diseases, including cystic fibrosis, bronchopneumonia, chronic obstructive pulmonary disease, and lung cancer, that are currently treated by systemic application of drugs, by oral intake, or aerosol inhalation.
In order to achieve therapeutic levels at the pathological site, physicians need to deliver large amounts of the drug that may cause adverse effects to other organs in the body. Lung diseases could be more effectively treated if the drug of choice could be delivered locally to the pathologic site in the lung, at the exact dose needed for the treatment.
"We envision that our micro-volume liquid instillation approach will enable predictable drug concentrations at the target site, reducing the amount of drug required for effective disease treatment with significantly reduced side effects," says Gordana Vunjak-Novakovic, Mikati Foundation Professor of Biomedical Engineering and professor of medical sciences (in Medicine), who supervised the work in her Laboratory for Stem Cells and Tissue Engineering.
The main challenge for the team was the enormous complexity of the lung structure that provides the vital function of oxygen and carbon dioxide exchange with the blood. Both the tissue architecture and the air flow change dramatically along the 24 generations of the lung airway, from the large bronchus down to the alveoli.
Jinho Kim, a postdoctoral fellow in Vunjak-Novakovic's lab and the lead author of the study, realized that the distance a liquid plug travels before being absorbed as liquid film can be varied by changing the plug volume and the regime of ventilation.
By studying liquid plugs in simple glass tubes, he developed a mathematical model describing liquid transport process in each generation of the airway tree. The model was used to determine the liquid plug volume and the parameters of programmed ventilation for delivery into a specific region of the lung. The model predictions were confirmed by demonstrating targeted liquid film deposition in ventilated lungs, using three different imaging modalities.
"Liquid instillation has been used for providing lung surfactant to the entire lungs in premature infants that cannot produce enough surfactant to breathe normally," Kim observes. "Although liquid instillation has great therapeutic potential, its applications have been unexplored, largely because of limited understanding of the liquid transport in the lung airways. We are very excited about the implications of our work."
The project has been a highly collaborative one, says Vunjak-Novakovic, whose team included three biomedical engineers, a lung transplant surgeon, and a pulmonologist: "This study is truly emblematic of how biomedical research is conducted at Columbia University."
Kim devised the approach for targeted delivery of micro-volumes of drugs, developed the necessary theory, and conducted the supporting experiments with John O'Neill, a biomedical engineering PhD student. At CUMC, Matt Bacchetta, associate professor of surgery, and Valerio Dorrello, assistant professor of pediatrics, helped define the clinically relevant parameters for drug delivery, and optimize lung ventilation and perfusion. The researchers plan next to demonstrate treatment of lung diseases such as cystic fibrosis and airway infections by delivering pulmonary drugs using their liquid instillation approach.
"We are fascinated by the opportunities that bioengineering approaches offer to more effectively treat lung disease," Vunjak-Novakovic adds. "The lung is a hugely complex organ that has billions of cells within a hierarchically organized tissue that cannot be built from scratch. Four years ago, we started research of lung regeneration using stem cells and bioengineering methods. And we continue to work with our clinical colleagues to develop new treatment approaches for treating lung disease."
This research has been supported by the National Institutes of Health (experimental and modeling studies), the Raymond and Beverly Sackler Foundation (pilot grant for Jinho Kim) and the Mikati Family Fund for Translational Research in Biomedical Engineering (development of a new system for lung ventilation and perfusion).
Paper -- http://www.
Vunjak-Novakovic -- http://bme.
Laboratory for Stem Cells and Tissue Engineering -- http://orion.
Columbia Engineering -- http://engineering.
CUMC -- http://www.
Holly Evarts | EurekAlert!
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
17.12.2018 | Physics and Astronomy
17.12.2018 | Architecture and Construction
17.12.2018 | Life Sciences